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A cDNA expression library constructed from mantle
tissue mRNA of the Mediterranean fan mussel Pinna
nobilis was screened with antibodies raised against the
acetic acid-soluble shell matrix of the same species. This
resulted in the isolation of a 2138-base pair cDNA, con-
taining 13 tandem repeats of 93 base pairs. The deduced
protein has a molecular mass of 66.7 kDa and a isoelec-
tric point of 4.8. This protein, which is enriched in serine
and proline residues, was overexpressed, purified, and
used for producing polyclonal antibodies. Immunologi-
cal in situ and in vitro tests showed that the protein is
localized in the nacreous aragonitic layer of P. nobilis,
but not in the calcitic prisms. Because this protein of the
nacre of P. nobilis exhibits some mucin-like character-
istics, we propose the name mucoperlin. This is the first
paper reporting the cloning of a molluscan mucin and
the first molecular evidence for the involvement of a
mucin in molluscan calcification. This finding corrobo-
rates our previous hypothesis that some of the protein-
aceous constituents of the molluscan shell matrix would
derive from mucins, common to many metazoan lin-
eages of the late Precambrian (Marin, F., Smith, M., Isa,
Y., Muyzer, G. and Westbroek, P. (1996) Proc. Natl. Acad.
Sci. U. S. A. 93, 1554–1559). The adaptation of an ances-
tral mucin to a new function, the regulation of the min-
eralization process, may be one of the molecular events,
among others, that would explain the simultaneous
emergence of organized calcification in many metazoan
lineages during the Cambrian explosion.
The skeletons produced by molluscs to protect and support
their soft bodies are organo-mineral amalgamates (1, 2) exhib-
iting a high degree of order at the nanoscale (3). As a rule, the
mineralized structure has mechanical properties far superior
to each of its constituent components. A well known example is
mother-of-pearl or nacre. Its micron-sized compact brick wall
texture is more than 1000 times tougher than the chemically
precipitated counterpart, aragonite (4).
A complex biochemical machinery is required for the produc-
tion of these highly ordered biominerals. Specialized microen-
vironments must be created to accommodate the growing min-
erals (1, 5). The constituent ions as well as macromolecules
capable of directing and fine-tuning the crystallization must be
supplied, while waste products of crystallization have to be
removed and deleterious precipitations avoided. The actual
biomineralization process follows as a remarkable case of self-
organization, with the densely packed organic-inorganic com-
posite emerging as the final product. Furthermore, the organ-
isms must deploy upstream the calcification, signal
transmitters (6, 7), and transcription factors (8, 9) able to
switch their biomineralizing machineries on and off.
Despite its complexity, it would appear as though the skele-
ton-forming machinery evolved with remarkable facility. The
skeletons of many animal phyla were installed in less than 30
million years, since the beginning of the Cambrian, 544 million
years ago (10, 11). Phylogenetic evidence derived from fossils
and morphology and DNA-sequencing of extant animals indi-
cate that major steps in animal diversification had already
been made prior to the “Cambrian explosion” (12–16). To ex-
plain how a function as complex as skeleton formation could
emerge in many independent stocks almost simultaneously, we
suggested that components of the mineralizing machinery were
already available in the soft bodied ancestors but that they
served other functions than calcification. Subsequently, during
the Cambrian explosion, they only had to be co-opted for orga-
nized biomineralization (17, 18). One indication supporting this
“preadaptation” hypothesis came from the observations by
Lopez and collaborators that molluscan nacre can induce bone
production in human osteoblasts (18–20). These experiments
suggest a common Precambrian ancestry for the responsible
signaling system in both taxa.
Another point to mention was our finding that secreted muci
and soluble shell matrix strongly cross-reacted with antisera
against these two antigens in various molluscs as well as in the
coral Galaxea fascicularis (17). Both the freshly extracted
muci, which were secreted by noncalcifying epithelia into the
ambient seawater, and the matrix fractions were shown to
inhibit the in vitro crystallization of calcium carbonate. We
explained these observations by assuming that the “anticalci-
fying” mucous secretions protected the soft bodied ancestors
from spontaneous incrustrations in the highly supersaturated
Precambrian ocean waters (17). At the onset of calcification,
the same inhibitory molecules could then be incorporated into
the calcifying machinery to fine-tune the crystallization proc-
ess. Clearly, this “anticalcification hypothesis” calls for a more
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detailed study of the macromolecular fractions in the mucous
secretions and the mineralized matrix.
In this paper, we report the isolation of a new gene encoding
a water-soluble protein of the nacroprismatic shell of the pro-
tected mollusc Pinna nobilis, the largest bivalve in the Medi-
terranean. The protein that we identified is acidic and enriched
in serine and proline residues. It is further characterized by the
presence of 13 tandem repeats with 31 amino acid residues and
a C terminus containing three unique cysteine residues. The
presence of tandem repeats, the enrichment in serine residues,
and its consequent potential of high glycosylation strongly sug-
gest that this protein is a mucin. The protein is localized in the
nacre but not in the prisms of P. nobilis. We chose to name it
mucoperlin, and we believe that its skeletal association is im-
portant evidence in support of our anticalcification hypothesis.
MATERIALS AND METHODS
Tissue and Shell Collection—Mantle tissue fragments from actively
calcifying, juvenile P. nobilis, grown in aquaria, were obtained. Tissue
collection was performed according to the European directive 92-43-
CEE concerning protected species (91). This operation did not affect the
viability and filtration capacity of the animal. The isolated tissue (about
0.5 g) was immediately frozen in liquid nitrogen.
Shell material was collected from two different batches of juvenile
specimens at CERAM (Centres d’Etudes des Ressources Animales Ma-
rines). The two layers of the shells (i.e. outer prismatic calcitic layer and
inner aragonitic mother-of-pearl) were separated by abrasion and by
dissociation of the calcitic prisms in dilute sodium hypochlorite.
Construction of the cDNA Expression Library—Total RNA was ex-
tracted from 0.5 g of mantle tissue using the RNAgents® Total RNA
Isolation System (Promega). The extraction yielded about 70 mg of RNA.
Poly(A)-mRNA was subsequently isolated with Oligotexy Resin (Qia-
gen). Approximately 1.5 mg mRNA was obtained and immediately pro-
cessed using the ZAPy Express cDNA synthesis kit (Stratagene), even-
tually yielding double-stranded XhoI–EcoRI cDNA fragments.
Approximately 70 ng of cDNA was ligated to 1 mg of XhoI/EcoRI-
predigested dephosphorylated ZAP Express vector. Subsequent pack-
aging of recombinant phages was performed with Gigapack® II Gold
Packaging Extract (Stratagene). The resulting phage library consisted
of 350,000 clones, of which at least 95% were found to be recombinant.
Prior to the antibody screening, the library was amplified.
Antibody Screening of the cDNA Expression Library—The amplified
library was screened with antibodies raised against acetic acid-soluble
extracts of the nacreous layer of P. nobilis (21). About 500,000 phages
were used in the initial screening. After infection of Escherichia coli
XL1-Blue MRF9, cells were plated and grown for 4 h at 42 °C. The plates
were covered with isopropyl-1-thio-b-D-galactopyranoside-saturated ni-
trocellulose membranes (BA85; Schleicher & Schuell) and incubated at
37 °C for an additional 5 h. Membranes were first blocked in 1% gelatin/
Tris-buffered saline/Tween solution and then incubated in blocking
solution containing the antiserum (diluted 1:3000), NaN3 (500 mg/ml),
and phenylmethylsulfonyl fluoride (100 mg/ml). An E. coli extract (1
mg/ml) was added to decrease background staining. The membranes
were then incubated with the conjugated antibody GAR/AP (Sigma) and
subsequently with the chemoluminescent substrate CSPD® (Roche Mo-
lecular Biochemicals) before being exposed to X-Omat films (Eastman
Kodak Co.). Eleven positive clones were identified, and three of them
were rescreened to purity. In a two-step in vivo excision, the pBK-CMV
phagemids (Stratagene) with their cDNA inserts were excised from the
purified ZAP Express phage clones and converted into the plasmids
pPNC1–pPNC3.
Nucleotide Sequence Analysis—Enzyme restriction analysis of plas-
mids pPNC1–3 showed similar PstI and XhoI restriction patterns con-
sisting of a 2100-base pair (bp)1 PstI and a ,100-bp PstI–XhoI frag-
ment. Partial nucleotide sequences determined from the 59- and 39-
termini further confirmed that the three clones contained identical
inserts. The sequence of the cDNA insert of pPCN1 was determined
using 59-deletions made with the Erase-a-Base® System (Promega).
Sequences were compiled and analyzed with the Wisconsin Package
(version 9.0) of the Genetics Computer Group. The GenBanky acces-
sion number for the sequence of the cDNA insert of pPNC1 is AF
145215.
Polyclonal Antibodies against the Recombinant Mucoperlin—The
cDNA insert of pPNC1 was cloned as a BamHI–KpnI fragment in vector
pQE-32 (QIAexpress® Expression System; Qiagen). In the resulting
construct, pPNC4, the putative start codon on the cDNA insert is cloned
in frame with the start codon of the T5 promoter transcription-trans-
lation system of pQE-32. Cloning in ZAP Express (pBK-CMV) and the
above described subcloning in pQE-32 resulted in the addition of an
extra fragment of 33 bp to the 59-end of the original cDNA. This
fragment encoded a 11-amino acid peptide (MRGSHHHHHHG) with a
molecular mass of 1.5 kDa. The His-tagged recombinant protein was
expressed from pPNC4 in E. coli M15 and purified using Ni21-nitrilo-
triacetic acid chromatography (Qiagen). A complete purification of the
recombinant protein was achieved by using a preparative electrophore-
sis (Bio-Rad; 491 Prep Cell, 7% acrylamide). On denaturing gels (SDS-
polyacrylamide gel electrophoresis), the fusion protein migrated as an
80-kDa band, in good agreement with the molecular weight as deduced
from the sequence (Fig. 1). Recombinant mucoperlin was desalted by
ultrafiltration (Amicon, YM10 membrane), lyophilized, and used to
generate polyclonal antibodies in a rabbit.
Mucoperlin in Extracts of Nacre and Prisms—To investigate whether
native mucoperlin is present in either the nacreous or in the prismatic
layer of P. nobilis shell or in both, ;100-mg portions of both cleaned
shell materials (batch 1) were powdered and dissolved overnight in 6 ml
of 20% (w/v) EDTA, pH 8.0. Insoluble material was removed by centrif-
ugation (5 min, 13,000 rpm). Demineralization with EDTA instead of
acetic acid permitted direct analysis of the supernatant by ELISA and
dot-blot (22), using anti-mucoperlin.
To study the intimacy of association between the native mucoperlin
and the mineral phase (23) and possible contamination of shell matrix
by soft tissues (24), nacre powder was submitted to a pretreatment with
sodium hypochlorite (2 g of active chlorine/liter) for 70 h, washed with
water, dried, and dissolved in EDTA. The resulting extract was com-
pared with EDTA-extracts of nonpretreated material in ELISA assays.
For electrophoretic analysis, 3 g of hypochlorite-treated powders
from juvenile nacre and prisms was decalcified overnight at 4 °C with
5% (v/v) acetic acid, pH 4. Acid decalcification precluded the formation
of aggregates during the subsequent purification steps, a phenomenon
often observed when EDTA is used (25). The solutions were centrifuged,
and the supernatants were desalted by ultrafiltration (Amicon, YM10)
and lyophilized. The pellets were thoroughly rinsed with water and
lyophilized. The lyophilized preparations were denatured in Laemmli
sample buffer for 5 min at 100 °C (26). After a short centrifugation, the
denatured samples were applied on 12% acrylamide gels. Gels were
either stained with silver (27) or electroblotted on ImmobilonTM-P (Mil-
lipore Corp.) (28). Immunodetection of blotted proteins with anti-mu-
coperlin was performed using the chemoluminescent substrate Luminol
(Sigma catalog no. A4685) (29).
Assays of Nacre Matrix Glycosylation—The second batch of shell
material was used to determine the degree of glycosylation of nacre
matrix. Because the amount of this batch was limited, only a few assays
could be performed. Part of the acetic acid-soluble extract of hypochlo-
rite-treated nacre was run on a 12% SDS-polyacrylamide gel and sub-
sequently blotted as described above. The blot was stained with the
Immun-Blot kit for glycoproteins (Bio-Rad catalog no. 170-6490). The
procedure involves periodate oxidation, labeling with biotin, incubation
with streptavidin-AP, and staining with 5-bromo-4-chloro-3-indolyl
phosphate/nitro blue tetrazolium. In one sample of nacre matrix, the
periodate oxidation was omitted to ascertain the specificity of the stain-
ing (negative control). Fetuin was used as a positive control.
The other part of the acid-soluble matrix was submitted to chemical
deglycosylation with TFMS (Sigma catalog no. T 1394) for 5 h, as
described by Edge et al. (30). To prevent peptide bond hydrolysis, all
procedures were performed at 0 °C under N2. The deglycosylated matrix
was desalted and concentrated by ultrafiltration and lyophilized. The
matrix was then analyzed on Western blots with anti-mucoperlin as
described above. Fetuin was deglycosylated by the same method to
check the efficiency of the procedure.
Interaction with Calcium and Inhibition of Calcium Carbonate Pre-
cipitation—Acetic acid-soluble nacre matrix extracted from the second
batch was also tested for 45Ca binding capacity, according to a standard
protocol (31). The assays were performed after dot-blotting the whole
matrix on polyvinylidene difluoride membranes at various concentra-
tions as indicated in the legend of Fig. 7. GPA, a calcium-binding
protein from a unicellular calcifying alga (32), was used as a positive
control. Furthermore, the capacity of the nacre matrix to inhibit cal-
cium carbonate precipitation in vitro was also tested (33).
1 The abbreviations used are: bp, base pair(s); ELISA, enzyme-linked
immunosorbent assay; MCP, mucoperlin; rec-MCP, recombinant muco-
perlin; TFMS, trifluoromethanesulfonic acid.
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In Situ Immunohistological Localization of Native Mucoperlin—Ju-
venile and adult P. nobilis cleaned shell fragments were polished with
micropolish powder (0.05 mm), thoroughly rinsed with water, and
slightly etched with EDTA 1% (w/v) during 15 min, to expose antigenic
determinants. The material was then immunostained as described pre-
viously (17, 34) and viewed by microscope under incident light.
RESULTS
Isolation and Characterization of mcp—Clone PNC1 was
isolated from a P. nobilis cDNA library using antibodies
against the soluble matrix of Pinna nacre. Analysis of its insert
gave a nucleotide sequence of 2138 bp (Fig. 1). We assume the
ATG at positions 208–210 to be the start codon of an open
reading frame of 1908 bp, encoding a gene referred to as mcp.
The cDNA contains a 59-untranslated region of 208 bp and a
truncated 39-untranslated region of only 23 bp. A poly(A) tail is
missing at the 39-end. This is probably due to an internal XhoI
restriction recognition site in the original mRNA.
Characterization of the mcp-encoded Protein—The mcp-en-
coded protein mucoperlin (Fig. 1) encompasses 636 amino acid
residues and has a calculated molecular mass of 66.7 kDa and
a pI of 4.8 (Table I). The two most abundant amino acids are
proline and serine (Table I). Mucoperlin comprises three dis-
tinct regions (schematically presented in Fig. 2): a short N-
terminal part (11 amino acids), a tandem repeat region (403
amino acids), and a C-terminal part (222 amino acids). The
tandem-repeat region consists of 13 repeats (Fig. 2). They all
contain 31 amino acids, 12 of which are invariant through the
repeats. Only few substitutions occur, mostly in the second half
of each repeat.
The primary structure of mucoperlin (Figs. 1 and 2) indicates
that the natural molecule may be heavily glycosylated, partic-
ularly in the tandem repeat region. Four possible N-glycosyla-
tion sites, characterized by NX(S/T) (where X may be any
amino acid except proline), occur in this region. The tandem
repeat region also exhibits many potential O-glycosylation
sites, as suggested by its high serine and threonine content. A
search performed with the NetOGlyc 2.0 program (35) predicts
that 27 serines are glycosylated in that region (i.e. one to three
serines per repeat) (Figs. 1 and 2). Prosite analysis and a
search made with NetPhos 2.0 (36) suggested that some of the
serine and threonine residues may be phosphorylated, a fea-
ture commonly found with proteins associated with mineral-
ized tissues (1). A high content of proline (17% of the residues)
is another characteristic feature of the tandem repeat region,
suggesting that this part of the molecule has a rigid, rodlike
conformation (37, 38).
The C-terminal region of mucoperlin has different character-
istics than the repeat region. Glycosylation appears to be less
densely distributed (Fig. 1), potentially with only one N-glyco-
sylation site at position 625 and three O-glycosylation sites
through threonine residues at positions 418, 465, and 472. On
the other hand, phosphorylation sites may be more densely
distributed, according to both Prosite and NetPhos 2.0 analy-
sis. Proline and serine are less common (8 and 10%, respec-
tively, of the C-terminal amino acids), although their abun-
dance is relatively high as compared with values of 5.1 and
6.9% for proteins in general (39). Furthermore, the only three
cysteine residues in mucoperlin occur in the C-terminal region,
at positions 596, 604, and 631, respectively. Finally, the C-
FIG. 1. Nucleotide sequence of mcp. The amino acid sequence of
mucoperlin is shown under the nucleotide sequence in one-letter sym-
bols. Mucoperlin contains 13 tandem repeats; the first repeat is boxed,
and the last amino acid residue of each repeat is indicated and num-
bered 1–13. The three cysteine residues in the C terminus are indicated
in bold, and the two potentially sulfated tyrosine residues are under-
lined. The XhoI restriction site at the 39-end is double underlined and
indicated with x. Serine and threonine residues representing possible
O-glycosylation sites (see Ref. 35) are indicated in boldface italic type.
N-Glycosylation motifs are indicated by gray rectangles.
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terminal region contains also the five tyrosine residues of the
protein, two of them (at positions 482 and 517) showing all of
the requirements for tyrosine sulfation (40).
BLAST searches (41) in protein and DNA-translated data
bases showed limited homology of mucoperlin with any other
known protein. The highest homology was found with PGM, an
incompletely characterized pig gastric mucin (42) that exhibits
serine-rich tandem repeats of 16 amino acid residues (Fig. 3A).
The C terminus of mucoperlin did not exhibit any homology
with a mucin. A striking homology was observed between a set
of 24 residues (positions 425–448) and the N terminus of a
chicken homeobox protein Hox-A9 (Ref. 43; Fig. 3B).
Mucoperlin in Extracts of Nacre and Prisms of P. nobilis—
The results of immunodetection of mucoperlin in EDTA ex-
tracts of nacreous and prismatic shell material (batch 1) of P.
nobilis are shown in Fig. 4, A and B. The reactions were
performed using ELISA and dot-blotting with the antiserum
directed against His-tagged recombinant mucoperlin. Mucoper-
lin was only detected in the nacre and not in the prisms. ELISA
analysis on hypochlorite-treated nacre did not affect the reac-
tivity of the antibody with the extract (Fig. 4C). We conclude
that the immunological signals did not originate from soft
tissue contamination. Furthermore, this result suggests that
mucoperlin is either strongly adsorbed on the mineral surface
or that it occupies an “intracrystalline” position (23).
The nacre specificity of anti-mucoperlin as determined with
ELISA and dot-blot analysis was verified with SDS-polyacryl-
amide gel electrophoresis and Western blotting on acetic acid-
soluble extracts from juvenile aragonitic nacre and calcitic
prisms (Fig. 5). Laemmli-soluble extracts of the two acetic
acid-insoluble fractions were also included in the analysis. Sil-
ver staining of the gels showed the presence of numerous dis-
crete thin bands in a background smear (Fig. 5A). All extracts
showed distinctively different patterns. Western blot analysis
proved that mucoperlin was only present in the nacre matrices
(Fig. 5B). Neither the acetic acid- nor the Laemmli-soluble
fractions of the prisms showed any reaction with
anti-mucoperlin.
In the acetic acid-soluble fraction of the nacre, a prominent
anti-mucoperlin-positive band with an apparent molecular
mass around 55 kDa was detected. We assumed this band to
represent native mucoperlin. The diffuse smear below this
band may indicate degradation or differences in glycosylation
of the native protein. The 55-kDa protein is also visible as
a major discrete band on silver-stained gels (Fig. 5A). In
Laemmli extracts of the insoluble nacre matrix, two closely
apposed anti-mucoperlin positive bands are visible with appar-
ent molecular masses around 30 kDa. This indicates that mu-
coperlin-related proteins remain associated with the insoluble
matrix after acid extraction of the nacre. These positive bands
may represent breakdown products of mucoperlin, generated
by the combined hypochlorite and Laemmli treatments, or dif-
ferent proteins closely resembling mucoperlin.
The apparent molecular mass of native mucoperlin (55 kDa,
Fig. 5A) is smaller than of the mcp deduced protein (66.7 kDa).
Heavily glycosylated proteins, like mucins, are known to be-
have anomalously upon electrophoresis (44); their mobility is
influenced by their intrinsic negative charge but also by the
fact that they bind very little SDS (45). It is also likely that
mucoperlin undergoes specific cleavage when incorporated into
the nacre or undergoes degradation due to aging of the nacre
layer (see below).
Deglycosylation Assays—The amino acid sequence of muco-
perlin suggests that the native molecule is heavily glycosy-
lated. In general, molluscan shell matrices have been shown to
contain an important sugar moiety (23, 46–48). This was con-
firmed by a specific glycoprotein staining of the Pinna nacre
matrix. Strong staining was obtained with many components of
the matrix, with the exception of low molecular weight frac-
tions (,20 kDa), which stained negatively (Fig. 6A). We as-
sume that at least part of nondegraded native mucoperlin is
represented by the stained band migrating slightly faster than
the 58.1-kDa marker (Fig. 6A, lanes 5 and 6). After deglycosy-
lation, no stained bands were visible.
Staining with anti-mucoperlin did not reveal such a discrete
anti-mucoperlin-positive band as obtained with the first batch
of shell (Fig. 5). Instead, a positive smear from 55 to 30 kDa,
TABLE I
Amino acid composition of mcp-deduced mucoperlin
n, number of residues. Data shown in parentheses represent the average occurrence of each amino acid, as determined for a large number of
proteins (see Ref. 39) (636 total amino acid residues; pI 5 4.87; theoretical mass 5 66.7 kDa).
Amino acid n Mole % Amino acid n Mole %
Ala 27 4.25 (8.3) Met 36 5.66 (2.4)
Cys 3 0.47 (1.7) Asn 13 2.04 (4.4)
Asp 30 4.72 (5.3) Pro 84 13.21 (5.1)
Glu 29 4.56 (6.2) Gln 38 5.98 (4.0)
Phe 3 0.47 (3.9) Arg 8 1.26 (5.7)
Gly 42 6.60 (7.2) Ser 93 14.62 (6.9)
His 1 0.16 (2.2) Thr 34 5.35 (5.8)
Ile 46 7.23 (5.2) Val 46 7.23 (6.6)
Lys 38 6.00 (5.7) Trp 1 0.16 (1.3)
Leu 59 9.28 (9.0) Tyr 5 0.79 (3.2)
FIG. 2. Schematic representation of mucoperlin. The protein
comprises a short 11-amino acid N terminus, a tandem repeat region
(residues 12–414), and a C terminus (residues 415–636) containing 3
cysteine residues (in boldface type). The 13 tandem repeats (31 amino
acids each) are aligned. TR, tandem repeat. *, the 12 amino acid
residues that are invariant throughout the repeats. Five of them are
serine residues. The potential sites for O-glycosylation are underlined.
In the second position, 10 serines out of 13 would be glycosylated and all
of the serine residues in the eighth as well. Boldface letters indicate
amino acids that occur at least twice in a given position, throughout the
repeats. Italics represent amino acids that appear only once.
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with a maximum between 40 and 30 kDa, was observed (Fig.
6B). Apparently, the mucoperlin in this shell batch had under-
gone more degradation than in the first batch. But clearly, the
positive signal shifted to lower molecular weights after degly-
cosylation (Fig. 6B, lane 2), indicating removal of sugar
residues.
Calcium Binding Assay and Inhibition of CaCO3 Precipita-
tion—The specific association of mucoperlin with the nacre
layer suggests that the molecule is functional in the calcifica-
tion process. This might imply that mucoperlin is able to inter-
act with Ca21 and/or to interfere with CaCO3 precipitation.
When tested in the CaCO3 precipitation assay as described by
Wheeler et al. (33), the recombinant mucoperlin did not delay
the precipitation of CaCO3. It did not appear to bind Ca
21
either when submitted to the Ca21 binding protocol on Western
blot as described by Maruyama and co-workers (31). We as-
sumed that potential interactions of the native mucoperlin
with Ca21 would be conveyed by its sugar moieties, as is the
case for many molluscan shell proteins (47, 48). The combined
acetic acid-soluble nacre matrix was able to bind Ca21 when
tested on dot-blots (Fig. 7A) and strongly inhibited CaCO3
FIG. 3. A, alignment of repeats 5–7 of MCP with those of PGM (accession number trEMBL Q29071), a pig gastric mucin. A gap was introduced
in each repeat of MCP to fit with the length of the doubled repeats of PGM. Identical ([vert]) and similar (:) amino acid residues are indicated. B,
a short portion of the C-teminus of MCP is aligned with the N terminus of chicken HoxA9 protein (accession number Swiss-Prot Q98924).
FIG. 4. Detection of native mucoperlin in different shell ex-
tracts. The anti-recombinant mucoperlin antibody was tested against
EDTA-soluble shell matrices of calcitic prisms and aragonitic nacre of
P. nobilis, via ELISA (A) and dot-blot (B). For more information, see
“Materials and Methods.” As a positive control, this antibody was also
tested against its target antigen, the recombinant mucoperlin (rec-
MCP). A, M, 1 ng of rec-MCP; , 0.5 ng of rec-MCP; f, 0.25 ng of
rec-MCP; l , 0.1 ng of rec-MCP; f, 0.05 ng of rec-MCP; M, SM nacre; l ,
SM nacre, diluted 10 times; E, SM prisms. C, the reactivity of the EDTA
extract with the anti-rec-MCP antibody was tested before (black curve)
and after (gray curve) a pretreatment of nacre powder with dilute
sodium hypoclorite (2 g of active chlorine/liter for 70 h). This pretreat-
ment did not significantly affect the immunological reactivity.
FIG. 5. Characterization of mucoperlin in CH3COOH extracts
of P. nobilis shell on 12% SDS-polyacrylamide gels (A) and West-
ern blots (B). The gel was stained with silver; the blot was revealed
with the chemoluminescent substrate Luminol. In each lane, equivalent
amounts of matrices were applied (about 10 mg). Lane 1, molecular
mass standards (from top to bottom): 94, 67, 43, 30, 20.1, and 14.4 kDa;
lane 2, CH3COOH-soluble matrix of the nacre; lane 3, Laemmli-soluble
fraction of the CH3COOH-insoluble matrix of the nacre; lane 4,
CH3COOH-soluble matrix of the calcitic prisms; lane 5, Laemmli-solu-
ble fraction of the CH3COOH-insoluble matrix of the prisms; lane 6,
recombinant mucoperlin. B, the arrow on the right side of the blot
indicates the position of the recombinant mucoperlin. A, lane 4 exhibits
a strong negative staining with silver. In CH3COOH-soluble extracts of
the nacre, the mucoperlin migrates as a thick band with an apparent
molecular mobility between that of bovine serum albumin (67 kDa) and
of ovalbumin (43 kDa).
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crystallization (Fig. 7B). However, individual Ca21 binding
components could not be demonstrated on Western blots with
the protocol of Maruyama et al. (not shown), probably as a
result of the denaturing conditions during electrophoresis. This
was confirmed by the inhibition of Ca21 binding by SDS and
b-mercaptoethanol in the dot-blot assay (Fig. 7A). Conse-
quently, we could not determine from these experiments
whether native mucoperlin is one of the nacre components that
interact with Ca21.
In Situ Localization of Mucoperlin—The outer, prismatic
layer of the P. nobilis shell is made of long, thin prisms of
calcite with a length of 1–3 mm and a diameter between 50 and
100 mm. Each prism is composed of a pile of thin crystallites, all
with identical optical axes (49). The internal, nacreous layer
consists of flat aragonite tablets, approximately 0.5–1 mm
thick. The tablets are stacked in a characteristic mortar-and-
brick structure (3, 50). The transition between the two layers is
abrupt, with sometimes an organic sheet (50-mm thickness) in
between. The in situ experiments on thin transversal EDTA-
etched adult shell sections (Fig. 8) confirm the nacre location of
mucoperlin. The nacre layer is stained purple as a result of a
positive reaction with anti-mucoperlin, whereas the prismatic
layer does not stain at all (Fig. 8B). Mucoperlin might also be
localized in the heavily pigmented organic layer between the
two microstructures. However, none of our assays permitted us
to visualize the presence of mucoperlin in that layer. The stain-
ing pattern of the nacre layer on transverse sections is not
uniform. At low magnification, it reveals short diffuse purple
lines more or less perpendicular to the growth plane (Fig. 8B).
At higher magnification, the lower and upper surface of each
nacre tablet are finely underlined by the staining, while pre-
dominant staining is observed on the short sides of each tablet
(Fig. 8C). In any case, mucoperlin was seen to form a continu-
ous sheet around each crystallite of the nacre. Furthermore,
sections parallel to the growth plane of juvenile nacre show
that mucoperlin is concentrated along the outlines of the tablet
(Fig. 8, D and E).
DISCUSSION
Calcified skeletons are formed by the intricate interplay
between inorganic ions and a variety of organic macromole-
cules, collectively called the skeletal organic matrix (1, 2, 5). In
a previous paper (17), we proposed that some components of the
soluble skeletal matrix of corals and molluscs were recruited
from mucous secretions of the Precambrian uncalcified ances-
tors. Originally, these materials would have been involved in
the protection of soft tissues against mineral encrustment in
the highly supersaturated oceans of the late Precambrian (51).
This anticalcification hypothesis was based on immunological
cross-reactivities between water-soluble skeletal matrices and
mucous secretions as well as on the ability of both materials to
inhibit calcium carbonate crystallization in vitro. A drawback
of this earlier work was the lack of biochemical information on
the secreted macromolecules. This paper supports our hypoth-
esis by providing convincing structural evidence that at least
some skeletal matrix components evolved from mucous
secretions.
We isolated a novel gene (mcp) from an expression library of
the bivalve P. nobilis with antibodies raised against the acetic
acid soluble skeletal matrix from Pinna nacre. The encoded
protein mucoperlin shows homology with mucins, a broad fam-
ily of proteins (37, 38, 45) and important constituents of meta-
zoan mucous secretions.
FIG. 6. Glycosylation study of mucoperlin on Western blots,
using the glycoprotein detection kit from Bio-Rad (A, lanes 3–9)
and the anti-recombinant mucoperlin on acetic acid-soluble na-
cre extracts (B, lanes 1–3), before and after chemical deglycosy-
lation with TFMS. Gel A, lane 1, glycosylated fetuin, Coomassie
Brilliant Blue-stained; lane 2, TFMS-deglycosylated fetuin, Coomassie
Brilliant Blue-stained; lane 3, glycosylated fetuin; lane 4, TFMS-degly-
cosylated fetuin; lane 5, nondeglycosylated acetic acid-soluble extract
from nacre, batch 2; lane 6, nondeglycosylated acetic acid-soluble ex-
tract from nacre, batch 1; lane 7, TFMS-deglycosylated acetic acid-
soluble extract from nacre, batch 2; lane 8, biotinylated markers, re-
spectively 58.1, 39.8, 29, 20.1, and 14.3 kDa; lane 9, same as lane 5,
without treatment with periodate (negative control). The position of
mucoperlin is indicated by a bar, between lanes 5 and 6. Gel B, lane 1,
nondeglycosylated acetic acid-soluble extract from nacre, batch 2; lane
2, TFMS-deglycosylated acetic acid-soluble extract from nacre, batch 2;
lane 3, recombinant mucoperlin; lane 4, molecular mass markers,
stained with Coomassie Brilliant Blue. The position of mucoperlin is
indicated by a bar between lanes 1 and 2.
FIG. 7. Calcium binding (7A) and in
vitro inhibition of calcium carbonate
precipitation (7B) assays. A, the acetic
acid-soluble matrix of nacre-bound cal-
cium only in nondenaturing conditions. In
presence of Laemmli sample buffer, this
effect was drastically reduced. GPA and
rabbit albumin are positive and negative
controls, respectively. In B, the same ma-
trix exhibited a strong inhibiting effect.
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Numerous mucin genes have been determined, from proto-
zoans to vertebrates (52–57), but among the molluscs they have
not yet been identified. So far, the single molluscan mucus
proteins, which have been genetically characterized are few
lectins of the land slug (58, 59). Mucins are heavily glycosylated
and sometimes sulfated proteins of which the sugar moiety can
amount to 85% of the total weight (38, 56). The protein cores
(apomucins) are characterized by the presence of numerous
tandem repeats in their central region. The repeats vary in size
from 6 (60) up to 169 (61) amino acids. They all contain many
serine and threonine residues, a large proportion of which
constitute O-glycosylation sites. The protein cores of mucins
are also rich in helix-breaking proline residues, accounting for
the rigid rodlike structure of the proteins (37, 38). Mucins are
able to form disulfide-dependent soluble dimers (56, 62) and
multimeric insoluble gels through cross-linking of cysteine-
enriched domains in the C- and N-terminal parts of the mole-
cules (63, 64). They act as lubricants protecting the underlying
epithelial tissues against viruses, bacteria, and other harmful
agents. Furthermore, they play a role in selective interactions
with the environment and in cellular recognition processes
(65). Our idea of an anticalcifying function is well in agreement
with the multifunctional nature of mucous materials.
Mucoperlin has many of the structural features characteris-
tic of mucins. The core region has 13 tandem repeats rich in
serine, threonine, and proline. These residues, important de-
terminants of glycosylation and protein conformation, all occur
at conserved positions (see Fig. 2). Also indicative is the con-
centration of the 3 cysteine residues of mucoperlin in the C-
terminal region. This suggests that mucoperlin may form tail-
to-tail dimers.
We did not find N-terminal cysteines, although these occur in
virtually all mucins studied. Note that MUC7 (66), a water-
soluble mucin from human saliva, and RSM, a rat submandib-
ular mucin (67), contain only two cysteine residues, both local-
ized at the N terminus. Thus, as MUC7 and RSM, mucoperlin
FIG. 8. In situ localization of muco-
perlin in the shell of P. nobilis, with
the antirecombinant MCP antibody.
For technical details, see “Materials and
Methods” and Refs. 17 and 34. In trans-
versal section, the shell presents a nacro-
prismatic microstructure, with long cal-
citic prisms (Fig. 8, A and B, upper yellow
compartment) and a nacreous layer (Fig.
8, A and B, lower compartment). The two
calcified layers are generally separated by
an organic layer, 50–60 mm thick (brown
line, Fig. 8, A and B). The nacreous layer
is composed a succession of minute arago-
nitic tablets (approximately 1-mm thick).
A, negative control with preserum of anti-
rec-MCP, diluted 104 times. B, staining
with anti-rec-MCP, diluted 104 times. C,
same section, high magnification. The
staining reveals horizontal lines, which
delineate the upper and lower surfaces of
each tablet. The predominant staining oc-
curs, however, on the short lateral sides of
the tablets. D, longitudinal section (par-
allel to the growth plane of the nacre) in a
juvenile P. nobilis shell. This preparation
confirms that mucoperlin is localized
around the polygonal elements (size
about 15–20 mm) of the nacre. E, same
preparation, high magnification.
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appears to be anomalous in this respect. On the other hand, we
cannot exclude the possibility that our isolate of mcp is incom-
plete at the 59-end. Our identification of the start codon of mcp
should be confirmed with Northern analysis, reverse tran-
scriptase-polymerase chain reaction amplification of the
mRNA 59 terminus, and genomic cloning. This work could not
be carried out for this study because fresh tissue material of the
protected species P. nobilis can only rarely be made available.
The specific association of mucoperlin with nacre tablets and
not with the prisms indicates that the protein plays a func-
tional role in the calcification process and is not a haphazard
inclusion in the shell. This observation confirms our previous
experiments (17), where we found a specific localization of
mucous-homologous soluble matrix components in the shell of
the bivalve mollusc Mercenaria mercenaria.
What could be the role of mucoperlin in the formation of
nacre? Weiner and Traub (68) proposed a hypothetical model
that would describe nacre formation (see also Refs. 1, 2, and
69). Insoluble matrix components would form a hydrophobic
chamber-like framework to which soluble, acidic proteins rich
in Asp/Glu-X or Asp/Glu-Ser-X motifs would be attached,
adopting a b-sheet conformation. These repetitive acidic motifs
would induce CaCO3 nucleation and promote epitaxial growth
of the crystals or, in contrast, terminate crystal growth when
covering growth surfaces (70). Structural information that be-
came available on various molluscan shell proteins in recent
years (71–76) indicates that the regulation of crystal growth
may be more subtle and complex; proteins such as nacrein (71),
MSI60 (72), lustrin A (73), N16 (75), N14, and N66 (76), all
from molluscan nacre, are clearly multifunctional. For exam-
ple, nacrein and MSI60 exhibit both calcium binding domains
and in addition a carbonic anhydrase function (for the first one)
and a set of hydrophobic motifs (for the second one). N16, a
newly discovered protein comprising at least three isoforms,
exhibits four short acidic regions and a heparin-binding-like
domain. Lustrin A is characterized by an alternation of proline-
rich and cysteine-rich modules and a long GS domain puta-
tively forming a “glycine loop.” The C terminus of lustrin A
presents a short basic domain and a protease inhibitor-like
domain. Although lustrin A is thought to be mainly responsible
of the toughness of nacre (77), additional functions are pre-
dicted from its sequence. Lustrin A may be a member of a
protein family, since another protein related to lustrin A has
been recently isolated (78). The cloning of mucoperlin, the first
mucin-like protein to be localized in a molluscan nacre, extends
one step more our view on molluscan calcification. Further-
more, it emphasizes the role of mucins in metazoan
mineralization.
Mucins have indeed been shown to be associated with calci-
fication in different mineralizing systems: the buccal cavity,
where salivary mucins strongly bind to teeth hydroxyapatite
(79, 80) and protect the teeth against demineralization (81); the
gallbladder, where the mucin GBM promotes gallstone forma-
tion (82) but also delays the precipitation of calcium phosphate
(83); and urine, where urinary mucins modulate the shape of
calcium oxalates (84) and act as heterogeneous nucleants for
calcium salts (85). In molluscs, mucins have been suspected of
playing a role in calcification (86), but only little molecular
evidence has been given (87).
In the absence of a more comprehensive theory on molluscan
calcification than the proposed model, any suggestion for the
role of mucoperlin must be tentative (Fig. 9). It has been pre-
viously suggested (88–90) that the nucleating macromolecules
in nacre were located in the central part of the nacre polygons.
Our observation that mucoperlin snugly surrounds the nacre-
ous tablets (see Fig. 8) might indicate that its primary role
would be to terminate crystal growth, in a way, similar to the
mechanism described by Wheeler et al. (70). This hypothesis
would be in agreement with the idea that the original function
of mucoperlin in ancestral stocks would have been anticalcifi-
cation, i.e. to inhibit spontaneous encrustration of soft tissues.
We observed that acetic acid-soluble extracts of nacre of P.
nobilis containing mucoperlin, could bind calcium, when non-
denatured, and strongly inhibited the precipitation of calcium
carbonate in vitro. It is not yet clear whether these roles are
played solely by mucoperlin or are the result of the interaction
between different components of the nacre matrix. Further
studies are required to isolate large amounts of native muco-
perlin from nacre extracts and to characterize this protein in
vitro. In particular, attention has to be given to its glycosyl
moieties. Recent works (47, 48) demonstrated the importance
of protein-bound polysaccharides in the regulation of molluscan
calcification process. This, in combination with the study of the
temporospatial pattern of mcp gene expression by in situ hy-
FIG. 9. Schematic drawing of the localization of mucoperlin in the shell of P. nobilis. A, nacroprismatic microstructure of the shell. B,
mucoperlin (dark red) is localized in the nacreous layer, around the tablets. Since nacre tablets grow from a center and extend laterally, mucoperlin
may be involved in the lateral control of the growth.
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bridization, will finally permit elucidation of the function of
mucoperlin in molluscan calcification and identification of the
cell types that contribute to mucoperlin deposition in nacre
tissues.
Acknowledgments—F. M. thanks Dr. D. Sellos and Dr. Van
Vormhout (Laboratoire de Biologie Marine du Colle`ge de France) for
teaching him the basic techniques of molecular biology.
REFERENCES
1. Lowenstam, H. A., and Weiner, S. (1989) On Biomineralization, Oxford Uni-
versity Press, New York
2. Addadi, L., and Weiner, S. (1992) Angew. Chem. Int. Ed. Engl. 31, 153–169
3. Carter, J. W. (ed) (1990) Skeletal Biomineralization: Patterns, Processes, and
Evolutionary Trends, Van Nostrand Reinhold, New York
4. Jackson, A., Vincent, J., and Turner, R. (1988) Proc. R. Soc. Lond. B 234,
415–425
5. Wilbur, K. M., and Saleuddin, A. S. M. (1983) The Mollusca, Vol. 4 (Saleuddin,
A. S. M., and Wilbur, K. M., eds) pp. 235–287, Academic Press, Inc., New
York
6. Rosen, V., and Thies, R. S. (1992) Trends Genet. 8, 97–102
7. Reddi, A. H. (1997) Cytokine Growth Factor Rev. 8, 11–20
8. Dickman, S. (1997) Science 276, 1502
9. Rodan, G. A., and Harada, S. (1997) Cell 89, 677–680
10. Lowenstam, H. A., and Margulis, L. (1980) Biosystems 12, 27–41
11. Bengtson, S. (1992) The Proterozoic Earth: A Multidisciplinary Study (Schopf,
J. W., and Klein, C., eds) pp. 397–411, Cambridge University Press, Cam-
bridge, UK
12. Ayala, F. J., Rzhetsky, A., and Ayala, F. J. (1998) Proc. Natl. Acad. Sci. U. S. A.
95, 606–611
13. Bromham, L., Rambaut, A., Fortey, R., Cooper, A., and Penny, D. (1998) Proc.
Natl. Acad. Sci. U. S. A. 95, 12386–12389
14. Adoutte, A., Balavoine, G., Lartillot, N., and de Rosa, R. (1999) Trends Genet.
15, 104–108
15. Valentine, J. W., Jablonski, D., and Erwin, D. H. (1999) Development 126,
851–859
16. Knoll, A. H., and Caroll, S. B. (1999) Science 284, 2129–2137
17. Marin, F., Smith, M., Isa, Y., Muyzer, G., and Westbroek, P. (1996) Proc. Natl.
Acad. Sci. U. S. A. 93, 1554–1559
18. Westbroek, P., and Marin, F. (1998) Nature 392, 861–862
19. Lopez, E., Vidal, B., Berland, S., Camprasse, S., Camprasse, G., and Silve, C.
(1992) Tissue Cell 24, 667–679
20. Atlan, G., Balmain, N., Berland, S., Vidal, B., and Lopez, E. (1997) C. R. Acad.
Sci. Paris Ser. III 320, 253–258
21. Marin, F., Muyzer, G., and Dauphin, Y. (1994) C. R. Acad. Sci. Paris Ser. III
318, 1653–1659
22. Collins, M. J., Curry, G. B., Muyzer, G., Quinn, R., Zomerdijk, T., and
Westbroek, P. (1988) Hist. Biol. (Paris) 1, 207–224
23. Crenshaw, M. A. (1972) Biomineralization 6, 6–11
24. Gaffey, S., and Bronnimann, C. E. (1993) J. Sediment. Petrol. 63, 752–754
25. Wheeler, A. P., Rusenko, K. W., George, J. W., and Sikes, C. S. (1987) Comp.
Biochem. Physiol. B Comp. Biochem. 87, 953–960
26. Laemmli, U. K. (1970) Nature 227, 680–685
27. Myers, J. M., Veis, A., Sabsay, B., and Wheeler, A. P. (1996) Anal. Biochem.
240, 300–302
28. Towbin, H., Staehelin, T., and Gordon, J. (1979) Proc. Natl. Acad. Sci. U. S. A.
76, 4350–4354
29. Leong, M. M. L., Milstein, C., and Pannell, R. (1986) J. Histochem. Cytochem.
34, 1645–1650
30. Edge, A. S. B., Faltynek, C. R., Hof, L., Reichert, L. E., Jr., and Weber, P.
(1981) Anal. Biochem. 118, 131–137
31. Maruyama, K., Mikawa, T., and Ebashi, S. (1984) J. Biochem. (Tokyo) 95,
511–519
32. Corstjens, P. L. A. M., van der Kooij, A., Linschooten, C., Brouwers, G. J.,
Westbroek, P., and deVrind-de Jong, E. (1998) J. Phycol. 34, 622–630
33. Wheeler, A. P., George, J. W., and Evans, C. A. (1981) Science 212, 1397–1398
34. Muyzer, G., and Westbroek, P. (1989) Geochim. Cosmochim. Acta 53,
1699–1702
35. Hansen, J. E., Lund, O., Tolstrup, N., Gooley, A. A., Williams, K. L., and
Brunak, S. (1998) Glycoconj. J. 15, 115–130
36. Blom, N., Gammeltoft, S., and Brunak, S. (1999) J. Mol. Biol. 294, 1351–1362
37. Jentoft, N. (1990) Trends Biochem. Sci. 15, 291–294
38. Hilkens, J., Ligtenberg, M. J. L., Vos, H. L., and Litinov, S. V. (1992) Trends
Biochem. Sci. 17, 359–363
39. McCaldon, P., and Argos, P. (1988) Proteins 4, 99–122
40. Huttner, W. B. (1987) Trends Biochem. Sci. 12, 361–363
41. Pearson, W., and Lipman, W. J. (1988) Proc. Natl. Acad. Sci. U. S. A. 85,
2444–2448
42. Turner, B. S., Bhaskar, K. R., Hadzopoulou-Cladaras, M., Specian, R. D., and
Lamont, J. T. (1995) Biochem. J. 308, 89–96
43. Gaunt, S. J., and Strachan, L. (1996) Dev. Dyn. 207, 270–280
44. Tytgat, K. M. A. J., Swallow, D. M., Van Klinken, B. J. W., Bu¨ller, H. A.,
Einerhand, A. W. C., and Dekker, J. (1995) Biochem. J. 310, 1053–1054
45. Van Klinken, B. J. W., Einerhand, A. W., Bu¨ller, H. A., and Dekker, J. (1998)
Anal. Biochem. 265, 103–116
46. Dauphin, Y., and Marin, F. (1995) Experientia 51, 278–283
47. Albeck, S., Weiner, S., and Addadi, L. (1996) Chem. Eur. J. 2, 278–284
48. Marxen, J. C., Hammer, M., Gehrke, T., and Becker, W. (1998) Biol. Bull. 194,
231–240
49. Cuif, J. P., Denis, A., Flamand, D., and Fre´rotte, B. (1985) Sci. Rep. Port-Cros
Natl. Park Fr. 11, 95–107
50. Schmidt, W. J. (1924) Zool. Jahrb. Abt. Anat. Ontog. Tiere 45, 1–148
51. Knoll, A. K., Fairchild, I. J., and Swett, K. (1993) Palaios 8, 512–525
52. Di Noia, J. M., Sanchez, D. O., and Frasch, A. C. C. (1995) J. Biol. Chem. 270,
24146–24149
53. Wang, P., and Granados, R. R. (1997) J. Biol. Chem. 272, 16663–16669
54. Theopold, U., Samakovlis, C., Erdjument-Bromage, H., Dillon, N., Axelsson,
B., Scmidt, O., Tempst, P., and Hultmark, D. (1997) J. Biol. Chem. 271,
12708–12715
55. Gendler, S. J., and Spicer, A. P. (1995) Annu. Rev. Physiol. 57, 607–634
56. Gum, J. R., Jr. (1996) Biochem. Soc. Trans. 23, 795–799
57. Seregni, E., Botti, C., Massaron, S., Lombardo, C., Capobianco, A., Bogni, A.,
and Bombardieri, E. (1997) Tumori 83, 625–632
58. Yusa, H. J., Furuta, E., Nakamura, A., and Takagi, T. (1998) Comp. Biochem.
Physiol. B Comp. Biochem. 119, 479–484
59. Kurachi, S., Song, Z. W., Takagaki, M., Yang, Q., Winter, H. C., Kurachi, K.,
and Goldstein, I. J. (1998) Eur. J. Biochem. 254, 217–222
60. Gum, J. R., Jr., Hicks, J. W., Lagace, R. E., Byrd, J. C., Toribara, N. W.,
Siddiki, B., Fearney, F. J., Lamport, D. T., and Kim, Y. S. (1991) J. Biol.
Chem. 266, 22733–22738
61. Toribara, N. W., Robertson, A. M., Ho, S. B., Kuo, W. L., Gum, E., Hicks, J. W.,
Gum, J. R., Jr., Byrd, J. C., Siddiki, B., and Kim, Y. S. (1993) J. Biol. Chem.
268, 5879–5885
62. Perez-Vilar, J., Eckhardt, A. E., and Hill, R. L. (1998) J. Biol. Chem. 271,
9845–9850
63. Perez-Vilar, J., Eckhardt, A. E., DeLuca, A., and Hill, R. L. (1998) J. Biol.
Chem. 273, 14442–14449
64. Axelsson, M. A. B., Asker, N., and Hansson, G. C. (1998) J. Biol. Chem. 273,
18864–18870
65. Amerongen, A. V. N., Bolscher, J. G. M., Bloemena, E., and Veerman, E. C. I.
(1998) Biol. Chem. 379, 1–18
66. Bobek, L. A., Tsai, H., Biesbrock, A. R., and Levine, M. J. (1993) J. Biol. Chem.
268, 20563–20569
67. Albone, E. F., Hagen, F. K., VanWuyckhuyse, B. C., and Tabak, L. (1994)
J. Biol. Chem. 269, 16845–16852
68. Weiner, S., and Traub, W. (1984) Phil. Trans. R. Soc. Lond. B Biol. Sci. 304,
425–434
69. Addadi, L., Moradian, J., Shay, E., Maroudas, N. G., and Weiner, S. (1987)
Proc. Natl. Acad. Sci. U. S. A. 84, 2732–2736
70. Wheeler, A. P., Rusenko, K. W., and Sikes, C. S. (1988) Chemical Aspects of
Regulation of Mineralization (Sikes, C. S., and Wheeler, A. P., eds) pp.
9–13, University of South Alabama Publication Services, Mobile, AL
71. Miyamoto, H., Miyashita, T., Okushima, M., Nakano, S., Morita, T., and
Matsushiro, A. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 9657–9660
72. Sudo, S., Fujikawa, T., Nagakura, T., Ohkubo, T., Sakagushi, K., Tanaka, M.,
Nakashima, K., and Takahashi, T. (1997) Nature 387, 563–564
73. Shen, X., Belcher, A. M., Hansma, P. K., Stucky, G. D., and Morse, D. E. (1997)
J. Biol. Chem. 272, 32472–32481
74. Sarashina, I., and Endo, K. (1998) Am. Mineral. 83, 1510–1515
75. Samata, T., Hayashi, N., Kono, M., Hasegawa, K., Horita, C., and Akera, S.
(1999) FEBS Lett. 462, 225–229
76. Kono, M., Hayashi, N., and Samata, T. (2000) Biochem. Biophys. Res. Com-
mun. 269, 213–218
77. Smith, B. L., Scha¨ffer, T. E., Viani, M., Thompson, J. B., Frederick, N. A.,
Kindt, J., Belcher, A., Stucky, G. D., Morse, D. E., and Hansma, P. K. (1999)
Nature 399, 761–763
78. Weiss, I. M., Kaufmann, S., Mann, K., and Fritz, M. (2000) Biochem. Biophys.
Res. Commun. 267, 17–21
79. Nieuw Amerongen, A. V., Oderkerk, C. H., and Veerman, E. C. I. (1989) J. Biol.
Buc. 17, 85–92
80. Tabak, L. A. (1995) Annu. Rev. Physiol. 57, 547–564
81. Nieuw Amerongen, A. V., Oderkerk, C. H., Veerman, E. C. I., and de Groot, K.
(1988) Adv. Biomater. 8, 327–330
82. Lechene de la Porte, P., Domingo, N., van Wijland, M., Groen, A. K., Ostrow,
J. D., and Lafont, H. (1996) J. Hepatol. 25, 339–348
83. Afdhal, N. H., Ostrow, J. D., Koehler, R., Niu, N., Groen, A. K., Veis, A., Nunes,
D. P., Offner, G. (1995) Gastroenterology 109, 1661–1672
84. Akbarieh, M., and Tawashi, R. (1991) Scanning Microsc. 5, 1019–1027
85. Grases, F., and Llobera, A. (1998) Micron 29, 105–111
86. Prezant, R. S. (1990) The Bivalvia: Proceedings of a Memorial Symposium in
Honour of Sir Charles Maurice Yonge, Edinburgh 1986 (Morton, B., ed.) pp.
83–95, Hong Kong University Press, Hong Kong
87. Marxen, J. C., and Becker, W. (1997) Comp. Biochem. Physiol. B Biol. Sci. 118,
23–33
88. Crenshaw, M. A., and Ristedt, H. (1976) The Mechanisms of Mineralization in
the Invertebrates and Plants (Watabe, N., and Wilbur, K. M., eds) pp.
355–367, University of South Carolina Press, Columbia, SC
89. Mutvei, H. (1980) The Mechanisms of Biomineralization in Animals and
Plants (Omori, M., and Watabe, N., eds) pp. 49–56, Tokai University Press,
Tokyo
90. Nakahara, H. (1991) Mechanisms and Phylogeny of Mineralization in Biolog-
ical Systems (Suga, S., and Nakahara, H., eds) pp. 343–350, Springer-
Verlag, Tokyo
91. European Economic Community (1992) Off. J. E. C. L206, 22.7.1992
Mucoperlin from the Nacre Matrix of P. nobilis 20675
 at W
A
LA
EU
S LIBRA
RY
 on M
ay 8, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Peter Westbroek
Frédéric Marin, Paul Corstjens, Béatrice de Gaulejac, Elizabeth de Vrind-De Jong and
PTERIOMORPHIA) 
SHELL LAYER OF THE FAN MUSSEL PINNA NOBILIS (BIVALVIA,
MUCOPERLIN, A NOVEL MUCIN-LIKE PROTEIN FROM THE NACREOUS 
Mucins and Molluscan Calcification: MOLECULAR CHARACTERIZATION OF
doi: 10.1074/jbc.M003006200 originally published online April 17, 2000
2000, 275:20667-20675.J. Biol. Chem. 
  
 10.1074/jbc.M003006200Access the most updated version of this article at doi: 
 Alerts: 
  
 When a correction for this article is posted•  
 When this article is cited•  
 to choose from all of JBC's e-mail alertsClick here
  
 http://www.jbc.org/content/275/27/20667.full.html#ref-list-1
This article cites 83 references, 27 of which can be accessed free at
 at W
A
LA
EU
S LIBRA
RY
 on M
ay 8, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
